Zage PE - Search Results

1

Overview and recent advances in the treatment of neuroblastoma.

Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Whittle SB, et al. Among authors: zage pe. Expert Rev Anticancer Ther. 2017 Apr;17(4):369-386. doi: 10.1080/14737140.2017.1285230. Epub 2017 Mar 15. Expert Rev Anticancer Ther. 2017. PMID: 28142287 Free article. Review.

2

Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.

Zage PE, Kletzel M, Murray K, Marcus R, Castleberry R, Zhang Y, London WB, Kretschmar C; Children's Oncology Group. Zage PE, et al. Pediatr Blood Cancer. 2008 Dec;51(6):747-53. doi: 10.1002/pbc.21713. Pediatr Blood Cancer. 2008. PMID: 18704922 Free PMC article.

3

New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.

Zage PE, Louis CU, Cohn SL. Zage PE, et al. Pediatr Blood Cancer. 2012 Jul 1;58(7):1099-105. doi: 10.1002/pbc.24116. Epub 2012 Feb 29. Pediatr Blood Cancer. 2012. PMID: 22378620 Free PMC article. Review.

4

The novel kinase inhibitor EMD1214063 is effective against neuroblastoma.

Scorsone K, Zhang L, Woodfield SE, Hicks J, Zage PE. Scorsone K, et al. Among authors: zage pe. Invest New Drugs. 2014 Oct;32(5):815-24. doi: 10.1007/s10637-014-0107-4. Epub 2014 May 16. Invest New Drugs. 2014. PMID: 24832869

5

Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition.

Zhang L, Scorsone K, Woodfield SE, Zage PE. Zhang L, et al. Among authors: zage pe. Cancer Chemother Pharmacol. 2015 Nov;76(5):977-87. doi: 10.1007/s00280-015-2871-z. Epub 2015 Sep 25. Cancer Chemother Pharmacol. 2015. PMID: 26407819

6

A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.

Whittle SB, Reyes S, Du M, Gireud M, Zhang L, Woodfield SE, Ittmann M, Scheurer ME, Bean AJ, Zage PE. Whittle SB, et al. Among authors: zage pe. J Pediatr Hematol Oncol. 2016 Mar;38(2):131-8. doi: 10.1097/MPH.0000000000000506. J Pediatr Hematol Oncol. 2016. PMID: 26840079 Free PMC article.

7

Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B.

Woodfield SE, Guo RJ, Liu Y, Major AM, Hollingsworth EF, Indiviglio S, Whittle SB, Mo Q, Bean AJ, Ittmann M, Lopez-Terrada D, Zage PE. Woodfield SE, et al. Among authors: zage pe. Genes Cancer. 2016 Jan;7(1-2):13-26. doi: 10.18632/genesandcancer.97. Genes Cancer. 2016. PMID: 27014418 Free PMC article.

8

CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.

Zage PE, Whittle SB, Shohet JM. Zage PE, et al. J Cell Biochem. 2017 Feb;118(2):221-231. doi: 10.1002/jcb.25656. Epub 2016 Aug 16. J Cell Biochem. 2017. PMID: 27428599 Review.

9

The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma.

Whittle SB, Patel K, Zhang L, Woodfield SE, Du M, Smith V, Zage PE. Whittle SB, et al. Among authors: zage pe. Invest New Drugs. 2016 Dec;34(6):685-692. doi: 10.1007/s10637-016-0387-y. Epub 2016 Sep 1. Invest New Drugs. 2016. PMID: 27586230

10

Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.

Whittle SB, Smith V, Silverstein A, Parmeter M, Minard CG, Bernhardt MB, Zage PE, Venkatramani R, Nuchtern JG, Heczey A, Russell HV, Shohet JM, Foster JH. Whittle SB, et al. Among authors: zage pe. Pediatr Blood Cancer. 2020 Oct;67(10):e28417. doi: 10.1002/pbc.28417. Epub 2020 Jul 30. Pediatr Blood Cancer. 2020. PMID: 32729196 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page